Virtual Research & Development Day to be held on September 12 at 8 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BMRN:
- BioMarin says first person treated commercially with ROCTAVIAN
- BioMarin participates in a conference call with Jefferies
- BioMarin treatment of hypochondroplasia granted FDA orphan status
- BioMarin price target lowered to $108 from $118 at Stifel
- BioMarin raises FY23 non-GAAP EPS view to $1.85-$2.10 from $1.80-$2.05